These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15249618)

  • 21. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E genotype and lifetime cognitive decline.
    Kozauer NA; Mielke MM; Chan GK; Rebok GW; Lyketsos CG
    Int Psychogeriatr; 2008 Feb; 20(1):109-23. PubMed ID: 17711604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hormone replacement therapy on self-reported cognitive symptoms: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Reboussin BA; Greendale GA; Espeland MA
    Climacteric; 1998 Sep; 1(3):172-9. PubMed ID: 11907941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of hormone replacement therapy on the aging-related change in cognitive performance. Analysis based on a Danish cohort study.
    Løkkegaard E; Pedersen AT; Laursen P; Loft IP; Larsen S; Jørgensen T
    Maturitas; 2002 Jul; 42(3):209-18. PubMed ID: 12161045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study.
    Van Gerven PW; Van Boxtel MP; Ausems EE; Bekers O; Jolles J
    Neuropsychology; 2012 Jul; 26(4):459-72. PubMed ID: 22642392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline.
    Bangen KJ; Beiser A; Delano-Wood L; Nation DA; Lamar M; Libon DJ; Bondi MW; Seshadri S; Wolf PA; Au R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1361-9. PubMed ID: 23601373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
    Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
    Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmenopausal hormone use and risk for colorectal cancer and adenoma.
    Grodstein F; Martinez ME; Platz EA; Giovannucci E; Colditz GA; Kautzky M; Fuchs C; Stampfer MJ
    Ann Intern Med; 1998 May; 128(9):705-12. PubMed ID: 9556463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen replacement therapy and cognitive decline in older community women.
    Matthews K; Cauley J; Yaffe K; Zmuda JM
    J Am Geriatr Soc; 1999 May; 47(5):518-23. PubMed ID: 10323642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons.
    Krell-Roesch J; Woodruff BK; Acosta JI; Locke DE; Hentz JG; Stonnington CM; Stokin GB; Nagle C; Michel BF; Sambuchi N; Caselli RJ; Geda YE
    J Neuropsychiatry Clin Neurosci; 2015; 27(4):322-5. PubMed ID: 25803305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical activity, including walking, and cognitive function in older women.
    Weuve J; Kang JH; Manson JE; Breteler MM; Ware JH; Grodstein F
    JAMA; 2004 Sep; 292(12):1454-61. PubMed ID: 15383516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of smoking and time on cognitive function in the elderly without dementia.
    Reitz C; Luchsinger J; Tang MX; Mayeux R
    Neurology; 2005 Sep; 65(6):870-5. PubMed ID: 16186526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
    Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
    Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone therapy and cognition: effects of timing and treatment type.
    Khoo SK; O'Neill S; Byrne G; King R; Travers C; Tripcony L
    Climacteric; 2010 Jun; 13(3):259-64. PubMed ID: 19886816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women.
    Grodstein F; Chen J; Willett WC
    Am J Clin Nutr; 2003 Apr; 77(4):975-84. PubMed ID: 12663300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study.
    Ryan J; Carrière I; Scali J; Dartigues JF; Tzourio C; Poncet M; Ritchie K; Ancelin ML
    Neurology; 2009 Nov; 73(21):1729-37. PubMed ID: 19933973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.